JPMorgan Chase & Co’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
15,367
+13,205
| +611% | +$132K | ﹤0.01% | 4588 |
|
|
2025
Q1 | $190K | Buy |
2,162
+243
| +13% | +$21.3K | ﹤0.01% | 4458 |
|
|
2024
Q4 | $178K | Buy |
1,919
+1,748
| +1,022% | +$162K | ﹤0.01% | 4577 |
|
|
2024
Q3 | $12.5K | Buy |
171
+5
| +3% | +$366 | ﹤0.01% | 5283 |
|
|
2024
Q2 | $9.67K | Buy |
166
+35
| +27% | +$2.04K | ﹤0.01% | 5265 |
|
|
2024
Q1 | $136K | Sell |
131
-83
| -39% | -$86K | ﹤0.01% | 4614 |
|
|
2023
Q4 | $169K | Buy |
214
+2
| +0.9% | +$1.58K | ﹤0.01% | 4532 |
|
|
2023
Q3 | $101K | Sell |
212
-19
| -8% | -$9.02K | ﹤0.01% | 4597 |
|
|
2023
Q2 | $138K | Buy |
231
+29
| +14% | +$17.4K | ﹤0.01% | 4477 |
|
|
2023
Q1 | $143K | Buy |
202
+52
| +35% | +$36.8K | ﹤0.01% | 4499 |
|
|
2022
Q4 | $154K | Sell |
150
-45
| -23% | -$46.2K | ﹤0.01% | 4324 |
|
|
2022
Q3 | $113K | Buy |
195
+27
| +16% | +$15.6K | ﹤0.01% | 4417 |
|
|
2022
Q2 | $92K | Sell |
168
-89
| -35% | -$48.7K | ﹤0.01% | 4670 |
|
|
2022
Q1 | $165K | Buy |
257
+85
| +49% | +$54.6K | ﹤0.01% | 4537 |
|
|
2021
Q4 | $71K | Buy |
172
+22
| +15% | +$9.08K | ﹤0.01% | 4949 |
|
|
2021
Q3 | $110K | Buy |
+150
| New | +$110K | ﹤0.01% | 4670 |
|